TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs294845
log Bayes Factor = 0.0295763
Chromosome 9   position 10,139,580  (GRCh37) Explore rs294845 on Ensembl!
Variant rs294845 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
N83.1 Corpus luteum cyst
0.097 0.903 0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.092 0.908 0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.090 0.910 0.000
N83.0 Follicular cyst of ovary
0.085 0.915 0.000
N83.3 Acquired atrophy of ovary and Fallopian tube
0.072 0.928 0.000
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube
0.069 0.931 0.000
N83.7 Haematoma of broad ligament
0.065 0.935 0.000
N83.4 Prolapse and hernia of ovary and Fallopian tube
0.060 0.940 0.000
C15.9 Oesophagus, unspecified
0.000 0.941 0.058
N83.6 Haematosalpinx
0.055 0.945 0.000
C15 Malignant neoplasm of oesophagus
0.000 0.950 0.050
C15.4 Middle third of oesophagus
0.000 0.952 0.048
C15.5 Lower third of oesophagus
0.000 0.953 0.047
C15.8 Overlapping lesion of oesophagus
0.000 0.964 0.036
C15.2 Abdominal part of oesophagus
0.000 0.964 0.036
C15.0 Cervical part of oesophagus
0.000 0.964 0.036
C15.1 Thoracic part of oesophagus
0.000 0.965 0.034
N83.2 Other and unspecified ovarian cysts
0.033 0.967 0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified
0.031 0.969 0.000
R59.0 Localised enlarged lymph nodes
0.000 0.969 0.031
Z85.6 Personal history of leukaemia
0.030 0.970 0.000
C15.3 Upper third of oesophagus
0.000 0.973 0.027
Z22.3 Carrier of other specified bacterial diseases
0.025 0.975 0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene
0.018 0.982 0.000
Z22 Carrier of infectious disease
0.014 0.986 0.000
Z22.8 Carrier of other infectious diseases
0.011 0.989 0.000
Z22.5 Carrier of viral hepatitis
0.011 0.989 0.000
Z22.9 Carrier of infectious disease, unspecified
0.010 0.989 0.000
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection
0.010 0.989 0.000
Z22.4 Carrier of infections with a predominantly sexual mode of transmission
0.010 0.989 0.000
Z22.2 Carrier of diphtheria
0.010 0.989 0.000
Z22.0 Carrier of typhoid
0.010 0.989 0.000
Z22.1 Carrier of other intestinal infectious diseases
0.010 0.990 0.000
Z92.4 Personal history of major surgery, not elsewhere classified
0.000 0.990 0.010
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.990 0.010
T51.0 Ethanol
0.000 0.991 0.009
T51 Toxic effect of alcohol
0.000 0.991 0.009
S52.00 Fracture of upper end of ulna (closed)
0.000 0.991 0.009
T58 Toxic effect of carbon monoxide
0.000 0.991 0.009
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.000 0.991 0.009
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)
0.000 0.992 0.008
T51.9 Alcohol, unspecified
0.000 0.992 0.008
D50.8 Other iron deficiency anaemias
0.008 0.992 0.000
T59 Toxic effect of other gases, fumes and vapours
0.000 0.992 0.007
T59.8 Other specified gases, fumes and vapours
0.000 0.993 0.007
T54 Toxic effect of corrosive substances
0.000 0.993 0.007
T63 Toxic effect of contact with venomous animals
0.000 0.993 0.007
T51.8 Other alcohols
0.000 0.993 0.007
T51.3 Fusel oil
0.000 0.993 0.007
T51.2 2-Propanol
0.000 0.993 0.007
T51.1 Methanol
0.000 0.993 0.007
T65 Toxic effect of other and unspecified substances
0.000 0.993 0.007
T55 Toxic effect of soaps and detergents
0.000 0.993 0.006
T60 Toxic effect of pesticides
0.000 0.994 0.006
T57 Toxic effect of other inorganic substances
0.000 0.994 0.006
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone
0.000 0.994 0.006
T52 Toxic effect of organic solvents
0.000 0.994 0.006
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants
0.000 0.994 0.006
T61 Toxic effect of noxious substances eaten as seafood
0.000 0.994 0.006
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.006 0.994 0.000
T63.4 Venom of other arthropods
0.000 0.994 0.006
T62 Toxic effect of other noxious substances eaten as food
0.000 0.994 0.006
T54.9 Corrosive substance, unspecified
0.000 0.994 0.006
T56 Toxic effect of metals
0.000 0.994 0.006
T59.7 Carbon dioxide
0.000 0.994 0.006
T59.6 Hydrogen sulphide
0.000 0.994 0.006
T59.5 Fluorine gas and hydrogen fluoride
0.000 0.994 0.006
T59.4 Chlorine gas
0.000 0.994 0.006
T59.3 Lachrymogenic gas
0.000 0.994 0.006
T59.2 Formaldehyde
0.000 0.994 0.006
T59.1 Sulphur dioxide
0.000 0.994 0.006
T59.0 Nitrogen oxides
0.000 0.994 0.006
K40 Inguinal hernia
0.005 0.995 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.995 0.005
T54.3 Corrosive alkalis and alklali-like substances
0.000 0.995 0.005
T54.2 Corrosive acids and acid-like substances
0.000 0.995 0.005
T54.1 Other corrosive organic compounds
0.000 0.995 0.005
T54.0 Phenol and phenol homologues
0.000 0.995 0.005
T63.8 Toxic effect of contact with other venomous animals
0.000 0.995 0.005
T63.6 Toxic effect of contact with other marine animals
0.000 0.995 0.005
T63.5 Toxic effect of contact with fish
0.000 0.995 0.005
T63.3 Venom of spider
0.000 0.995 0.005
T63.2 Venom of scorpion
0.000 0.995 0.005
T63.1 Venom of other reptiles
0.000 0.995 0.005
T63.0 Snake venom
0.000 0.995 0.005
D23.3 Skin of other and unspecified parts of face
0.005 0.995 0.000
T65.9 Toxic effect of unspecified substance
0.000 0.995 0.005
M21.0 Valgus deformity, not elsewhere classified
0.000 0.995 0.005
T65.8 Toxic effect of other specified substances
0.000 0.995 0.005
T65.6 Paints and dyes, not elsewhere classified
0.000 0.995 0.005
T65.5 Nitroglycerin and other nitric acids and esters
0.000 0.995 0.005
T65.4 Carbon disulphide
0.000 0.995 0.005
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues
0.000 0.995 0.005
T65.2 Tobacco and nicotine
0.000 0.995 0.005
T65.1 Strychnine and its salts
0.000 0.995 0.005
T65.0 Cyanides
0.000 0.995 0.005
T59.9 Gases, fumes and vapours, unspecified
0.000 0.995 0.005
T52.9 Organic solvent, unspecified
0.000 0.995 0.005
T52.8 Other organic solvents
0.000 0.995 0.005
T52.4 Ketones
0.000 0.995 0.005
T52.3 Glycols
0.000 0.995 0.005
T52.2 Homologues of benzene
0.000 0.995 0.005
T52.1 Benzene
0.000 0.995 0.005
T52.0 Petroleum products
0.000 0.995 0.005
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified
0.000 0.995 0.005
T53.7 Other halogen derivatives of aromatic hydrocarbons
0.000 0.995 0.005
T53.6 Other halogen derivatives of aliphatic hydrocarbons
0.000 0.995 0.005
T53.5 Chlorofluorocarbons
0.000 0.995 0.005
T53.4 Dichloromethane
0.000 0.995 0.005
T53.3 Tetrachloroethylene
0.000 0.995 0.005
T53.2 Trichloroethylene
0.000 0.995 0.005
T53.1 Chloroform
0.000 0.995 0.005
T53.0 Carbon tetrachloride
0.000 0.995 0.005
T57.9 Inorganic substance, unspecified
0.000 0.995 0.005
T57.8 Other specified inorganic substances
0.000 0.995 0.005
T57.3 Hydrogen cyanide
0.000 0.995 0.005
T57.2 Manganese and its compounds
0.000 0.995 0.005
T57.1 Phosphorus and its compounds
0.000 0.995 0.005
T57.0 Arsenic and its compounds
0.000 0.995 0.005
T60.9 Pesticide, unspecified
0.000 0.995 0.005
T60.8 Other pesticides
0.000 0.995 0.005
T60.4 Rodenticides
0.000 0.995 0.005
T60.3 Herbicides and fungicides
0.000 0.995 0.005
T60.2 Other insecticides
0.000 0.995 0.005
T60.1 Halogenated insecticides
0.000 0.995 0.005
T60.0 Organophosphate and carbamate insecticides
0.000 0.995 0.005
T63.9 Toxic effect of contact with unspecified venomous animal
0.000 0.995 0.005
T61.9 Toxic effect of unspecified seafood
0.000 0.995 0.005
T61.8 Toxic effect of other seafoods
0.000 0.995 0.005
T61.1 Scombroid fish poisoning
0.000 0.995 0.005
T61.0 Ciguatera fish poisoning
0.000 0.995 0.005
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene
0.005 0.995 0.000
K65.0 Acute peritonitis
0.000 0.995 0.005
Z82.3 Family history of stroke
0.005 0.995 0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.005 0.995 0.000
T61.2 Other fish and shellfish poisoning
0.000 0.995 0.004
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
0.005 0.995 0.000
T62.8 Other specified noxious substances eaten as food
0.000 0.995 0.004
T62.2 Other ingested (parts of) plant(s)
0.000 0.995 0.004
T62.1 Ingested berries
0.000 0.995 0.004
T62.0 Ingested mushrooms
0.000 0.995 0.004
T56.9 Metal, unspecified
0.000 0.995 0.004
T56.7 Beryllium and its compounds
0.000 0.995 0.004
T56.6 Tin and its compounds
0.000 0.995 0.004
T56.5 Zinc and its compounds
0.000 0.995 0.004
T56.4 Copper and its compounds
0.000 0.995 0.004
T56.3 Cadmium and its compounds
0.000 0.995 0.004
T56.2 Chromium and its compounds
0.000 0.995 0.004
T56.1 Mercury and its compounds
0.000 0.995 0.004
T56.0 Lead and its compounds
0.000 0.995 0.004
S12.20 Fracture of other specified cervical vertebra (closed)
0.000 0.996 0.004
T39.1 4-Aminophenol derivatives
0.000 0.996 0.004
Z04.8 Examination and observation for other specified reasons
0.000 0.996 0.004
T62.9 Noxious substance eaten as food, unspecified
0.000 0.996 0.004
T39.0 Salicylates
0.000 0.996 0.004
Z24 Need for immunisation against certain single viral diseases
0.004 0.996 0.000
K40.1 Bilateral inguinal hernia, with gangrene
0.004 0.996 0.000
T39.4 Antirheumatics, not elsewhere classified
0.000 0.996 0.004
T39.2 Pyrazolone derivatives
0.000 0.996 0.004
T56.8 Other metals
0.000 0.996 0.004
M21.37 Wrist or foot drop (acquired) (Ankle and foot)
0.000 0.996 0.004
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.996 0.004
Z48.0 Attention to surgical dressings and sutures
0.004 0.996 0.000
M21.09 Valgus deformity, not elsewhere classified (Site unspecified)
0.000 0.996 0.004
M21.08 Valgus deformity, not elsewhere classified (Other)
0.000 0.996 0.004
M21.05 Valgus deformity, not elsewhere classified (Pelvic region and thigh)
0.000 0.996 0.004
M21.04 Valgus deformity, not elsewhere classified (Hand)
0.000 0.996 0.004
M21.03 Valgus deformity, not elsewhere classified (Forearm)
0.000 0.996 0.004
M21.02 Valgus deformity, not elsewhere classified (Upper arm)
0.000 0.996 0.004
M21.01 Valgus deformity, not elsewhere classified (Shoulder region)
0.000 0.996 0.004
M21.00 Valgus deformity, not elsewhere classified (Multiple sites)
0.000 0.996 0.004
S52.0 Fracture of upper end of ulna
0.000 0.996 0.004
Z24.5 Need for immunisation against rubella alone
0.004 0.996 0.000
Z26 Need for immunisation against other single infectious diseases
0.004 0.996 0.000
K40.4 Unilateral or unspecified inguinal hernia, with gangrene
0.004 0.996 0.000
Z27 Need for immunisation against combinations of infectious diseases
0.004 0.996 0.000
H43.1 Vitreous haemorrhage
0.000 0.996 0.004
H43 Disorders of vitreous body
0.000 0.996 0.004
Z28 Immunisation not carried out
0.003 0.996 0.000
Z25 Need for immunisation against other single viral diseases
0.003 0.996 0.000
Z23 Need for immunisation against single bacterial diseases
0.003 0.996 0.000
H43.3 Other vitreous opacities
0.000 0.996 0.004
M21.3 Wrist or foot drop (acquired)
0.000 0.996 0.004
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.996 0.003
Q44.6 Cystic disease of liver
0.004 0.996 0.000
M21.06 Valgus deformity, not elsewhere classified (Lower leg)
0.000 0.996 0.003
K65.8 Other peritonitis
0.000 0.996 0.003
H43.8 Other disorders of vitreous body
0.000 0.997 0.003
Z20 Contact with and exposure to communicable diseases
0.003 0.997 0.000
H43.9 Disorder of vitreous body, unspecified
0.000 0.997 0.003
Z24.6 Need for immunisation against viral hepatitis
0.003 0.997 0.000
Z24.4 Need for immunisation against measles alone
0.003 0.997 0.000
Z24.3 Need for immunisation against yellow fever
0.003 0.997 0.000
Z24.2 Need for immunisation against rabies
0.003 0.997 0.000
Z24.1 Need for immunisation against arthropod-borne viral encephalitis
0.003 0.997 0.000
Z24.0 Need for immunisation against poliomyelitis
0.003 0.997 0.000
Z26.9 Need for immunisation against unspecified infectious disease
0.003 0.997 0.000
R59 Enlarged lymph nodes
0.000 0.997 0.003
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.003 0.997 0.000
M21 Other acquired deformities of limbs
0.000 0.997 0.003
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified
0.000 0.997 0.003
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]
0.003 0.997 0.000
C73 Malignant neoplasm of thyroid gland
0.003 0.997 0.000
K65 Peritonitis
0.000 0.997 0.003
H43.2 Crystalline deposits in vitreous body
0.000 0.997 0.003
Z26.8 Need for immunisation against other specified single infectious diseases
0.003 0.997 0.000
Z26.0 Need for immunisation against leishmaniasis
0.003 0.997 0.000
Z27.9 Need for immunisation against unspecified combinations of infectious diseases
0.003 0.997 0.000
Z27.8 Need for immunisation against other combinations of infectious diseases
0.003 0.997 0.000
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]
0.003 0.997 0.000
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]
0.003 0.997 0.000
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]
0.003 0.997 0.000
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]
0.003 0.997 0.000
Z49.0 Preparatory care for dialysis
0.003 0.997 0.000
M47.12 Other spondylosis with myelopathy (Cervical region)
0.000 0.997 0.003
O20.0 Threatened abortion
0.003 0.997 0.000
Z23.8 Need for immunisation against other single bacterial diseases
0.003 0.997 0.000
Z23.7 Need for immunisation against pertussis alone
0.003 0.997 0.000
Z23.6 Need for immunisation against diphtheria alone
0.003 0.997 0.000
Z23.5 Need for immunisation against tetanus alone
0.003 0.997 0.000
Z23.4 Need for immunisation against tularaemia
0.003 0.997 0.000
Z23.3 Need for immunisation against plague
0.003 0.997 0.000
Z23.2 Need for immunisation against tuberculosis [BCG]
0.003 0.997 0.000
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]
0.003 0.997 0.000
Z23.0 Need for immunisation against cholera alone
0.003 0.997 0.000
Z25.8 Need for immunisation against other specified single viral diseases
0.003 0.997 0.000
Z25.1 Need for immunisation against influenza
0.003 0.997 0.000
Z25.0 Need for immunisation against mumps alone
0.003 0.997 0.000
Z28.9 Immunisation not carried out for unspecified reason
0.003 0.997 0.000
Z28.8 Immunisation not carried out for other reasons
0.003 0.997 0.000
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons
0.003 0.997 0.000
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure
0.003 0.997 0.000
Z28.0 Immunisation not carried out because of contraindication
0.003 0.997 0.000
M21.39 Wrist or foot drop (acquired)-Site unspec
0.000 0.997 0.003
M21.38 Wrist or foot drop (acquired)-Other
0.000 0.997 0.003
M21.36 Wrist or foot drop (acquired)-Lower leg
0.000 0.997 0.003
M21.35 Wrist or foot drop (acquired)-Pelvic/thigh
0.000 0.997 0.003
M21.34 Wrist or foot drop (acquired) (Hand)
0.000 0.997 0.003
M21.32 Wrist or foot drop (acquired)-Upper arm
0.000 0.997 0.003
M21.31 Wrist or foot drop (acquired)-Shldr region
0.000 0.997 0.003
M21.30 Wrist or foot drop (acquired) (Multiple sites)
0.000 0.997 0.003
M21.33 Wrist or foot drop (acquired) (Forearm)
0.000 0.997 0.003
Z20.9 Contact with and exposure to unspecified communicable disease
0.003 0.997 0.000
Z29 Need for other prophylactic measures
0.003 0.997 0.000
S52.01 Fracture of upper end of ulna (open)
0.000 0.997 0.003
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations
0.002 0.997 0.000
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]
0.002 0.997 0.000
Z20.5 Contact with and exposure to viral hepatitis
0.002 0.997 0.000
Z20.4 Contact with and exposure to rubella
0.002 0.997 0.000
Z20.3 Contact with and exposure to rabies
0.002 0.997 0.000
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission
0.002 0.997 0.000
Z20.0 Contact with and exposure to intestinal infectious diseases
0.002 0.997 0.000
H43.0 Vitreous prolapse
0.000 0.997 0.003
L40.5 Arthropathic psoriasis
0.000 0.997 0.003
Z20.1 Contact with and exposure to tuberculosis
0.002 0.997 0.000
M21.9 Acquired deformity of limb, unspecified
0.000 0.997 0.003
G63.2 Diabetic polyneuropathy
0.003 0.997 0.000
H18.5 Hereditary corneal dystrophies
0.003 0.997 0.000
Z49.1 Extracorporeal dialysis
0.003 0.997 0.000
D63.8 Anaemia in other chronic diseases classified elsewhere
0.000 0.997 0.003
M21.6 Other acquired deformities of ankle and foot
0.000 0.997 0.003
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status
0.002 0.997 0.000
D37.9 Digestive organ, unspecified
0.003 0.997 0.000
S12.2 Fracture of other specified cervical vertebra
0.000 0.997 0.003
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot
0.000 0.997 0.003
Z29.8 Other specified prophylactic measures
0.003 0.997 0.000
M05.9 Seropositive rheumatoid arthritis, unspecified
0.003 0.997 0.000
Z48 Other surgical follow-up care
0.003 0.997 0.000
Z48.8 Other specified surgical follow-up care
0.003 0.997 0.000
M21.4 Flat foot [pes planus] (acquired)
0.000 0.998 0.002
M21.1 Varus deformity, not elsewhere classified
0.000 0.998 0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.998 0.002
O81.4 Vacuum extractor delivery
0.002 0.998 0.000
O81.3 Other and unspecified forceps delivery
0.002 0.998 0.000
M21.7 Unequal limb length (acquired)
0.000 0.998 0.002
Z20.8 Contact with and exposure to other communicable diseases
0.002 0.998 0.000
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)
0.000 0.998 0.002
Z29.0 Isolation
0.002 0.998 0.000
M21.27 Flexion deformity (Ankle and foot)
0.000 0.998 0.002
I49.4 Other and unspecified premature depolarisation
0.002 0.998 0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)
0.002 0.998 0.000
M21.97 Acquired deformity of limb, unspecified (Ankle and foot)
0.000 0.998 0.002
S50.9 Superficial injury of forearm, unspecified
0.002 0.998 0.000
O81 Single delivery by forceps and vacuum extractor
0.002 0.998 0.000
M21.8 Other specified acquired deformities of limbs
0.000 0.998 0.002
Z29.9 Prophylactic measure, unspecified
0.002 0.998 0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)
0.002 0.998 0.000
M21.2 Flexion deformity
0.000 0.998 0.002
O81.0 Low forceps delivery
0.002 0.998 0.000
M21.96 Acquired deformity of limb, unspecified (Lower leg)
0.000 0.998 0.002
M21.94 Acquired deformity of limb, unspecified (Hand)
0.000 0.998 0.002
T43.2 Other and unspecified antidepressants
0.000 0.998 0.002
M21.99 Acquired deformity of limb, unspecified (Site unspecified)
0.000 0.998 0.002
M21.98 Acquired deformity of limb, unspecified-Other
0.000 0.998 0.002
M21.95 Acquired deformity of limb, unspecified (Pelvic region and thigh)
0.000 0.998 0.002
M21.93 Acquired deformity of limb, unspecified (Forearm)
0.000 0.998 0.002
M21.92 Acquired deformity of limb, unspecified (Upper arm)
0.000 0.998 0.002
M21.91 Acquired deformity of limb, unspecified (Shoulder region)
0.000 0.998 0.002
M21.90 Acquired deformity of limb, unspecified (Multiple sites)
0.000 0.998 0.002
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)
0.002 0.998 0.000
M21.67 Other acquired deformities of ankle and foot-Ankle/foot
0.000 0.998 0.002
I51.8 Other ill-defined heart diseases
0.002 0.998 0.000
M21.54 Acquired clawhand, clubhand, clawfoot and clubfoot (Hand)
0.000 0.998 0.002
D45 Polycythaemia vera
0.002 0.998 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.998 0.002
I27.2 Other secondary pulmonary hypertension
0.000 0.998 0.002
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.002 0.998 0.000
N47 Redundant prepuce, phimosis and paraphimosis
0.002 0.998 0.000
Z49 Care involving dialysis
0.002 0.998 0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)
0.002 0.998 0.000
M21.69 Other acquired deformities of ankle and foot-Site unspec
0.000 0.998 0.002
M21.68 Other acquired deformities of ankle and foot-Other
0.000 0.998 0.002
M21.66 Other acquired deformities of ankle and foot-Lower leg
0.000 0.998 0.002
M21.65 Other acquired deformities of ankle and foot-Pelvic/thigh
0.000 0.998 0.002
M21.64 Other acquired deformities of ankle and foot-Hand
0.000 0.998 0.002
M21.63 Other acquired deformities of ankle and foot-Forearm
0.000 0.998 0.002
M21.62 Other acquired deformities of ankle and foot-Upper arm
0.000 0.998 0.002
M21.61 Other acquired deformities of ankle and foot-Shldr region
0.000 0.998 0.002
M21.60 Other acquired deformities of ankle and foot-Mult sites
0.000 0.998 0.002
C92.0 Acute myeloid leukaemia
0.002 0.998 0.000
S12.21 Fracture of other specified cervical vertebra (open)
0.000 0.998 0.002
D37.1 Stomach
0.002 0.998 0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)
0.002 0.998 0.000
M21.59 Acquired clawhand, clubhand, clawfoot and clubfoot-Site uns
0.000 0.998 0.002
M21.58 Acquired clawhand, clubhand, clawfoot and clubfoot-Other
0.000 0.998 0.002
M21.56 Acquired clawhand, clubhand, clawfoot and clubfoot-Lower le
0.000 0.998 0.002
M21.55 Acquired clawhand, clubhand, clawfoot and clubfoot-Pelvic/t
0.000 0.998 0.002
M21.53 Acquired clawhand, clubhand, clawfoot and clubfoot-Forearm
0.000 0.998 0.002
M21.52 Acquired clawhand, clubhand, clawfoot and clubfoot-Upper ar
0.000 0.998 0.002
M21.51 Acquired clawhand, clubhand, clawfoot and clubfoot-Shldr re
0.000 0.998 0.002
M21.50 Acquired clawhand, clubhand, clawfoot and clubfoot (Multiple sites)
0.000 0.998 0.002
C92.1 Chronic myeloid leukaemia
0.002 0.998 0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)
0.002 0.998 0.000
T36 Poisoning by systemic antibiotics
0.000 0.998 0.002
C90.2 Plasmacytoma, extramedullary
0.000 0.998 0.002
S30.8 Other superficial injuries of abdomen, lower back and pelvis
0.000 0.998 0.002
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)
0.000 0.998 0.002
M21.76 Unequal limb length (acquired) (Lower leg)
0.000 0.998 0.002
D43.0 Brain, supratentorial
0.002 0.998 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.998 0.002
M21.19 Varus deformity, not elsewhere classified (Site unspecified)
0.000 0.998 0.002
M21.18 Varus deformity, not elsewhere classified (Other)
0.000 0.998 0.002
M21.14 Varus deformity, not elsewhere classified (Hand)
0.000 0.998 0.002
M21.13 Varus deformity, not elsewhere classified (Forearm)
0.000 0.998 0.002
M21.12 Varus deformity, not elsewhere classified (Upper arm)
0.000 0.998 0.002
M21.11 Varus deformity, not elsewhere classified (Shoulder region)
0.000 0.998 0.002
M21.10 Varus deformity, not elsewhere classified (Multiple sites)
0.000 0.998 0.002
M21.49 Flat foot [pes planus] (acquired)-Site unspec
0.000 0.998 0.002
M21.48 Flat foot [pes planus] (acquired)-Other
0.000 0.998 0.002
M21.46 Flat foot [pes planus] (acquired)-Lower leg
0.000 0.998 0.002
M21.45 Flat foot [pes planus] (acquired)-Pelvic/thigh
0.000 0.998 0.002
M21.44 Flat foot [pes planus] (acquired)-Hand
0.000 0.998 0.002
M21.43 Flat foot [pes planus] (acquired)-Forearm
0.000 0.998 0.002
M21.42 Flat foot [pes planus] (acquired)-Upper arm
0.000 0.998 0.002
M21.41 Flat foot [pes planus] (acquired)-Shldr region
0.000 0.998 0.002
M21.40 Flat foot [pes planus] (acquired)-Mult sites
0.000 0.998 0.002
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.002 0.998 0.000
C18.7 Sigmoid colon
0.002 0.998 0.000
T36.0 Penicillins
0.000 0.998 0.002
M21.79 Unequal limb length (acquired) (Site unspecified)
0.000 0.998 0.002
M21.78 Unequal limb length (acquired)-Other
0.000 0.998 0.002
M21.77 Unequal limb length (acquired) (Ankle and foot)
0.000 0.998 0.002
M21.74 Unequal limb length (acquired) (Hand)
0.000 0.998 0.002
M21.72 Unequal limb length (acquired) (Upper arm)
0.000 0.998 0.002
M21.71 Unequal limb length (acquired)-Shldr region
0.000 0.998 0.002
M21.70 Unequal limb length (acquired) (Multiple sites)
0.000 0.998 0.002
O04.9 Complete or unspecified, without complication
0.002 0.998 0.000
Z48.9 Surgical follow-up care, unspecified
0.002 0.998 0.000
D37.5 Rectum
0.002 0.998 0.000
D37.2 Small intestine
0.002 0.998 0.000
T36.4 Tetracyclines
0.000 0.998 0.002
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)
0.002 0.998 0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified
0.002 0.998 0.000
M21.83 Other specified acquired deformities of limbs (Forearm)
0.000 0.998 0.002
D37.4 Colon
0.002 0.998 0.000
M05.2 Rheumatoid vasculitis
0.002 0.998 0.000
Z11.0 Special screening examination for intestinal infectious diseases
0.002 0.998 0.000
C92 Myeloid leukaemia
0.002 0.998 0.000
M05 Seropositive rheumatoid arthritis
0.002 0.998 0.000
M21.15 Varus deformity, not elsewhere classified (Pelvic region and thigh)
0.000 0.998 0.002
S82.30 Fracture of lower end of tibia (closed)
0.000 0.998 0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.998 0.002
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
M21.86 Other specified acquired deformities of limbs (Lower leg)
0.000 0.998 0.002
K86.3 Pseudocyst of pancreas
0.002 0.998 0.000
N90.9 Noninflammatory disorder of vulva and perineum, unspecified
0.000 0.998 0.002
O81.5 Delivery by combination of forceps and vacuum extractor
0.002 0.998 0.000
O81.2 Mid-cavity forceps with rotation
0.002 0.998 0.000
O81.1 Mid-cavity forceps delivery
0.002 0.998 0.000
T92.1 Sequelae of fracture of arm
0.002 0.998 0.000
M21.22 Flexion deformity (Upper arm)
0.000 0.998 0.002
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot
0.000 0.998 0.002
M21.73 Unequal limb length (acquired) (Forearm)
0.000 0.998 0.002
M21.89 Other specified acquired deformities of limbs (Site unspecified)
0.000 0.998 0.002
M21.88 Other specified acquired deformities of limbs-Other
0.000 0.998 0.002
M21.84 Other specified acquired deformities of limbs (Hand)
0.000 0.998 0.002
M21.82 Other specified acquired deformities of limbs (Upper arm)
0.000 0.998 0.002
M21.81 Other specified acquired deformities of limbs (Shoulder region)
0.000 0.998 0.002
M21.80 Other specified acquired deformities of limbs (Multiple sites)
0.000 0.998 0.002
D43.1 Brain, infratentorial
0.002 0.998 0.000
T92.2 Sequelae of fracture at wrist and hand level
0.002 0.998 0.000
M21.29 Flexion deformity (Site unspecified)
0.000 0.998 0.002
M21.28 Flexion deformity (Other)
0.000 0.998 0.002
M21.21 Flexion deformity (Shoulder region)
0.000 0.998 0.002
M21.75 Unequal limb length (acquired) (Pelvic region and thigh)
0.000 0.998 0.002
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)
0.000 0.998 0.002
T36.3 Macrolides
0.000 0.998 0.002
Q44 Congenital malformations of gallbladder, bile ducts and liver
0.002 0.998 0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)
0.002 0.998 0.000
K86.0 Alcohol-induced chronic pancreatitis
0.002 0.998 0.000
M05.1 Rheumatoid lung disease
0.002 0.998 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.002 0.998 0.000
M05.29 Rheumatoid vasculitis (Site unspecified)
0.002 0.998 0.000
M21.20 Flexion deformity (Multiple sites)
0.000 0.998 0.002
D43.4 Spinal cord
0.002 0.998 0.000
O23.4 Unspecified infection of urinary tract in pregnancy
0.002 0.998 0.000
T36.8 Other systemic antibiotics
0.000 0.998 0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.998 0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.998 0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.998 0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.998 0.002
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.998 0.002
T44.0 Anticholinesterase agents
0.000 0.998 0.002
M05.20 Rheumatoid vasculitis (Multiple sites)
0.002 0.998 0.000
C92.7 Other myeloid leukaemia
0.002 0.998 0.000
C92.5 Acute myelomonocytic leukaemia
0.002 0.998 0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves
0.002 0.998 0.000
M05.19 Rheumatoid lung disease (Site unspecified)
0.002 0.998 0.000
M21.24 Flexion deformity (Hand)
0.000 0.998 0.002
O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
0.002 0.998 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.998 0.002
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.998 0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.998 0.002
D37.6 Liver, gallbladder and bile ducts
0.002 0.998 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.998 0.002
T36.7 Antifungal antibiotics, systemically used
0.000 0.998 0.002
T36.6 Rifamycins
0.000 0.998 0.002
T36.5 Aminoglycosides
0.000 0.998 0.002
T36.2 Chloramphenicol group
0.000 0.998 0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.998 0.002
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.998 0.002
M05.0 Felty's syndrome
0.002 0.998 0.000
O23.5 Infections of the genital tract in pregnancy
0.002 0.998 0.000
T82.5 Mechanical complication of other cardiac and vascular devices and implants
0.002 0.998 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.998 0.002
T40.1 Heroin
0.000 0.998 0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.998 0.002
Z50.8 Care involving use of rehabilitation procedures
0.002 0.998 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.998 0.002
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.998 0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.998 0.002
M21.87 Other specified acquired deformities of limbs (Ankle and foot)
0.000 0.998 0.001
M21.85 Other specified acquired deformities of limbs (Pelvic region and thigh)
0.000 0.998 0.001
M54.22 Cervicalgia (Cervical region)
0.000 0.998 0.002
D43.9 Central nervous system, unspecified
0.002 0.998 0.000
D43.7 Other parts of central nervous system
0.002 0.998 0.000
D43.3 Cranial nerves
0.002 0.998 0.000
D63 Anaemia in chronic diseases classified elsewhere
0.000 0.998 0.002
M21.23 Flexion deformity (Forearm)
0.000 0.998 0.001
C92.4 Acute promyelocytic leukaemia
0.002 0.998 0.000
M05.8 Other seropositive rheumatoid arthritis
0.002 0.998 0.000
O42.1 Premature rupture of membranes, onset of labour after 24 hours
0.002 0.998 0.000
C92.9 Myeloid leukaemia, unspecified
0.002 0.998 0.000
K52.1 Toxic gastro-enteritis and colitis
0.002 0.998 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.998 0.002
T45.5 Anticoagulants
0.000 0.998 0.002
Z49.2 Other dialysis
0.002 0.998 0.000
O23 Infections of genito-urinary tract in pregnancy
0.002 0.998 0.000
C92.2 Subacute myeloid leukaemia
0.002 0.998 0.000
D48.1 Connective and other soft tissue
0.002 0.998 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.998 0.002
M05.09 Felty's syndrome (Site unspecified)
0.002 0.998 0.000
M05.28 Rheumatoid vasculitis (Other)
0.001 0.998 0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)
0.001 0.998 0.000
M05.26 Rheumatoid vasculitis (Lower leg)
0.001 0.998 0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)
0.001 0.998 0.000
M05.24 Rheumatoid vasculitis (Hand)
0.001 0.998 0.000
M05.23 Rheumatoid vasculitis (Forearm)
0.001 0.998 0.000
M05.22 Rheumatoid vasculitis (Upper arm)
0.001 0.998 0.000
M05.21 Rheumatoid vasculitis (Shoulder region)
0.001 0.998 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.002 0.998 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.002 0.998 0.000
C92.3 Myeloid sarcoma
0.002 0.998 0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems
0.002 0.998 0.000
Q44.5 Other congenital malformations of bile ducts
0.002 0.998 0.000
Z29.1 Prophylactic immunotherapy
0.001 0.998 0.000
D37.3 Appendix
0.002 0.998 0.000
R73.9 Hyperglycaemia, unspecified
0.002 0.998 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.998 0.002
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.002 0.998 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.002 0.998 0.000
O20 Haemorrhage in early pregnancy
0.002 0.998 0.000
M21.25 Flexion deformity (Pelvic region and thigh)
0.000 0.998 0.001
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.002 0.998 0.000
D48.2 Peripheral nerves and autonomic nervous system
0.002 0.998 0.000
D63.0 Anaemia in neoplastic disease
0.000 0.998 0.002
Q44.7 Other congenital malformations of liver
0.001 0.998 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.998 0.001
M05.18 Rheumatoid lung disease (Other)
0.001 0.998 0.000
M05.17 Rheumatoid lung disease (Ankle and foot)
0.001 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.